Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 167,509 0.300% |
-3,117,394 (-94.90%) |
Filing History |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Frazier Life Sciences Public Fund, L.P. | 1,500,000 2.500% |
-2,082,093 (-58.13%) |
Filing History |
| 2023-02-14 08:58 am Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Deep Track Capital, LP | 4,666,666 7.440% |
-1,191,163 (-20.33%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Citadel Advisors LLC | 541,341 0.900% |
-2,866,256 (-84.11%) |
Filing History |
| 2022-12-16 5:09 pm Sale |
2022-12-09 | 13D | TRICIDA INC TCDAQ |
Sibling Capital Ventures LLC | 0 0.000% |
-5,563,493 (Position Closed) |
Filing History |
| 2022-11-25 4:57 pm Sale |
2022-11-22 | 13D | TRICIDA INC TCDAQ |
ORBIMED ADVISORS LLC | 666,667 1.100% |
-8,951,245 (-93.07%) |
Filing History |
| 2022-10-28 4:05 pm Sale |
2022-10-25 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 2,982,528 5.400% |
-5,899,349 (-66.42%) |
Filing History |
| 2022-10-28 4:01 pm Purchase |
2022-10-18 | 13G | TRICIDA INC TCDAQ |
Citadel Advisors LLC | 3,407,597 6.100% |
3,407,597 (New Position) |
Filing History |
| 2022-10-19 5:07 pm Sale |
2022-10-12 | 13D | TRICIDA INC TCDAQ |
Sibling Capital Ventures LLC | 5,563,493 10.000% |
-860,000 (-13.39%) |
Filing History |
| 2022-09-28 9:20 pm Purchase |
2022-09-26 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 8,881,877 16.000% |
3,016,717 (+51.43%) |
Filing History |
| 2022-06-06 5:31 pm Purchase |
2022-06-01 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 5,865,160 10.600% |
2,370,309 (+67.82%) |
Filing History |
| 2022-05-16 12:57 pm Purchase |
2022-03-16 | 13G | TRICIDA INC TCDAQ |
Frazier Life Sciences Public Fund, L.P. | 3,582,093 6.300% |
3,582,093 (New Position) |
Filing History |
| 2022-03-24 4:15 pm Sale |
2022-03-22 | 13D | TRICIDA INC TCDAQ |
Sibling Capital Ventures LLC | 6,423,493 11.700% |
-192,841 (-2.91%) |
Filing History |
| 2022-02-14 4:39 pm Purchase |
2021-12-31 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 3,284,903 5.900% |
759,365 (+30.07%) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-11-17 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 3,494,851 6.300% |
3,494,851 (New Position) |
Filing History |
| 2021-11-23 4:10 pm Sale |
2021-11-15 | 13D | TRICIDA INC TCDAQ |
Sibling Capital Ventures LLC | 6,616,334 12.000% |
-47,860 (-0.72%) |
Filing History |
| 2021-11-17 4:11 pm Purchase |
2021-11-15 | 13G | TRICIDA INC TCDAQ |
Deep Track Capital, LP | 5,857,829 9.990% |
5,857,829 (New Position) |
Filing History |
| 2021-09-10 4:43 pm Sale |
2021-08-31 | 13G | TRICIDA INC TCDAQ |
MORGAN STANLEY MS |
619,459 1.200% |
-3,915,679 (-86.34%) |
Filing History |
| 2021-03-24 5:25 pm Purchase |
2021-03-23 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 2,525,538 5.000% |
2,525,538 (New Position) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | TRICIDA INC TCDAQ |
PRICE T ROWE ASSOCIATES INC | 1,158,637 2.300% |
-3,270,581 (-73.84%) |
Filing History |